Histopathology of Pleomorphic Adenoma in the Parotid Gland: a Prospective Unselected Series of 100 Cases
Overview
Affiliations
Objectives/hypothesis: Histopathological characteristics of pleomorphic adenomas, especially of capsular alterations such as thin capsule areas, capsule-free regions, capsule penetration, satellite nodules, and pseudopodia in the different subtypes, are described.
Study Design: Prospective unselected series of 100 consecutive cases from 1997 to 2000.
Methods: Light microscopic examination and semiquantitative analysis of the pleomorphic adenomas.
Results: Fifty-one (51%) pleomorphic adenomas were classified as myxoid (stroma-rich) type, 35 (35%) specimens as cellular type, and 14 (14%) as classic subtype. Ninety-seven percent of all tumors showed areas with thin (<20 microm) capsule independent of the tumor subtype. Tumors of myxoid subtype showed the absolute greatest regions of a thin capsule. Especially, tumors of myxoid type (71%) often had a distinct focal absence of encapsulation with tumor merging into normal parotid gland tissue; 11% of the cellular subtype and 43% of the classic subtype presented capsule-free areas. Thirty-three percent of the myxoid pleomorphic adenomas, 23% of the cellular subtype, and 21% of the classic subtype had satellite nodules or pseudopodia.
Conclusions: Almost all pleomorphic adenomas have focally thin capsules. One-fourth of all pleomorphic adenomas contain abnormalities such as satellite nodules or pseudopodia. More than two-thirds of pleomorphic adenomas of the myxoid (stroma-rich) subtype and at least half of all tumors show a focal absence of the capsule. Therefore, enucleation or local dissection of the pleomorphic adenoma is not a sufficient surgical treatment of this special tumor entity. We recommend, depending on the location of the tumor, a lateral or total parotidectomy as the treatment of choice.
Unusual metastasizing pleomorphic adenoma of the parotid gland involving locoregional lymph nodes.
SeyedForootan F, Motiee-Langroudi M, Moradi M, Aminishakib P Dent Res J (Isfahan). 2025; 22:4.
PMID: 40028507 PMC: 11870334. DOI: 10.4103/drj.drj_274_24.
Metastasizing Pleomorphic Adenoma: A Rare Entity.
Zainal Ariffin A, Lum S, Chong Sian N, Gan S Cureus. 2025; 17(1):e78085.
PMID: 40013185 PMC: 11864799. DOI: 10.7759/cureus.78085.
de Lima-Souza R, Belohlavkova K, Michal M, Altemani A, Mariano F, Skalova A Virchows Arch. 2025; .
PMID: 39827206 DOI: 10.1007/s00428-024-04015-z.
Metastasizing pleomorphic adenoma of parotid gland: Case report.
Tsai W, Kang B SAGE Open Med Case Rep. 2024; 12:2050313X241275339.
PMID: 39314217 PMC: 11418345. DOI: 10.1177/2050313X241275339.
Correlation between MRI (DWI and DCE) and cellularity of parotid gland pleomorphic adenomas.
Monestier L, Del Grande J, Haddad R, Santini L, Michel J, Varoquaux A Eur Arch Otorhinolaryngol. 2024; 281(5):2655-2665.
PMID: 38498193 DOI: 10.1007/s00405-024-08562-8.